138 related articles for article (PubMed ID: 9095333)
1. Antitumor activity of S 16020-2 in two orthotopic models of lung cancer.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Pierré A; Atassi G
Anticancer Drugs; 1997 Mar; 8(3):276-82. PubMed ID: 9095333
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
4. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
6. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
[TBL] [Abstract][Full Text] [Related]
7. Seasonal dependency of the effects of rotational stress and cyclophosphamide in mice bearing lewis lung carcinoma.
Zorzet S; Perissin L; Rapozzi V; Giraldi T
Brain Behav Immun; 2002 Aug; 16(4):368-82. PubMed ID: 12096884
[TBL] [Abstract][Full Text] [Related]
8. Experimental antitumour activity of S 16020-2 in a panel of human tumours.
Kraus-Berthier L; Guilbaud N; Jan M; Saint-Dizier D; Rouillon MH; Burbridge MF; Pierré A; Atassi G
Eur J Cancer; 1997 Oct; 33(11):1881-7. PubMed ID: 9470851
[TBL] [Abstract][Full Text] [Related]
9. Etoposide induction of tumor immunity in Lewis lung cancer.
Slater LM; Stupecky M; Sweet P; Osann K; Eklof A; Arquilla ER
Cancer Chemother Pharmacol; 2001 Oct; 48(4):327-32. PubMed ID: 11710634
[TBL] [Abstract][Full Text] [Related]
10. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells.
Magesh V; Lee JC; Ahn KS; Lee HJ; Lee HJ; Lee EO; Shim BS; Jung HJ; Kim JS; Kim DK; Choi SH; Ahn KS; Kim SH
Phytother Res; 2009 Oct; 23(10):1385-91. PubMed ID: 19277950
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
[TBL] [Abstract][Full Text] [Related]
12. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
13. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Touil YS; Seguin J; Scherman D; Chabot GG
Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336
[TBL] [Abstract][Full Text] [Related]
14. Preclinical antitumor activity of bizelesin in mice.
Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J
Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280
[TBL] [Abstract][Full Text] [Related]
15. [A semisynthetic flavonoid from the Baikal skullcap (Scutellaria baicalensis) as an agent to enhance the efficacy of chemotherapy in experimental tumors].
Razina TG; Zueva EP; Litvinenko VI; Kovalev IP
Eksp Klin Farmakol; 1998; 61(2):54-6. PubMed ID: 9621177
[No Abstract] [Full Text] [Related]
16. Schedule-dependent and -independent antitumor activity of paclitaxel-based combination chemotherapy against M-109 murine lung carcinoma in vivo.
Fujimoto S; Chikazawa H
Jpn J Cancer Res; 1998 Dec; 89(12):1343-51. PubMed ID: 10081496
[TBL] [Abstract][Full Text] [Related]
17. [Modulation of the antitumor effect of cyclophosphamide by the recombinant probiotic Subalin].
Cherdyntseva NV; Litviakov NV; Smol'ianinov ES; Beliavskaia VA; Masycheva VI
Vopr Onkol; 1997; 43(3):313-6. PubMed ID: 9245089
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
Da Silva SL; Chaar Jda S; Yano T
Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
[TBL] [Abstract][Full Text] [Related]
20. TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
Murakami K; Yamaura T; Suda K; Ohie S; Shibata J; Toko T; Yamada Y; Saiki I
Jpn J Cancer Res; 1999 Nov; 90(11):1254-61. PubMed ID: 10622538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
